비스포스포네이트 연관 악골괴사의 치료 방식과투약 휴지기가 치료 예후에 미치는 영향
The effectiveness of the surgical approach and drug-holiday on the treatment of bisphosphonate related osteonecrosis of the jaw patient
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The purpose of this study is to compare the surgical treatment with conservative treatment and to evaluate the effectiveness of drug-holiday in bisphosphonate related osteonecrosis of the jaw (BRONJ) patients who were diagnosed as stage 2. Patients and Method: From January 2012 to October 2014, seventy-two patients who visit to Pusan National University of Dental Hospital were diagnosed as stage 2 of BRONJ. All the patients had taken computed tomography(CT) and panoramic radiography. The surgical treatment including sequestrectomy of necrotic bone and curettage of soft tissue around the sequestrum were performed to fifty patients. Twenty-two patients underwent conservative treatment such as antibiotics medications, mouth rinsing and follow up checking for every two weeks. Prognosis of treatment was classified into 3 groups ? response, unresponse, and worsens - according to clinical, radiographic symptoms. P-value less than 0.05 were regarded as significant. Results: In surgery group, forty-five patients (90%) were healed without recurrence or any complication and five patients (10%) showed the wound dehiscence or infection. In conservative treatment group, fifteen patients (68.2%) were healed without any complication, four patients (18.2%) did not show improvement and three(4.2%) patients°Ø symptoms increased. P-value among groups was 0.014. Evaluation of preoperative drug-holiday in surgery group did not show the effectiveness(p=0.478). Conclusion: Statistically, the prognosis of patients with stage 2 BRONJ treated with surgery was significantly better than conservative treatment. There was no statistical difference for the preoperative drug-holiday.
Abstract
Objective: The purpose of this study is to compare the surgical treatment with conservative treatment and to evaluate the effectiveness of drug-holiday in bisphosphonate related osteonecrosis of the jaw (BRONJ) patients who were diagnosed as stage 2. Patients and Method: From January 2012 to October 2014, seventy-two patients who visit to Pusan National University of Dental Hospital were diagnosed as stage 2 of BRONJ. All the patients had taken computed tomography(CT) and panoramic radiography. The surgical treatment including sequestrectomy of necrotic bone and curettage of soft tissue around the sequestrum were performed to fifty patients. Twenty-two patients underwent conservative treatment such as antibiotics medications, mouth rinsing and follow up checking for every two weeks. Prognosis of treatment was classified into 3 groups ? response, unresponse, and worsens - according to clinical, radiographic symptoms. P-value less than 0.05 were regarded as significant. Results: In surgery group, forty-five patients (90%) were healed without recurrence or any complication and five patients (10%) showed the wound dehiscence or infection. In conservative treatment group, fifteen patients (68.2%) were healed without any complication, four patients (18.2%) did not show improvement and three(4.2%) patients°Ø symptoms increased. P-value among groups was 0.014. Evaluation of preoperative drug-holiday in surgery group did not show the effectiveness(p=0.478). Conclusion: Statistically, the prognosis of patients with stage 2 BRONJ treated with surgery was significantly better than conservative treatment. There was no statistical difference for the preoperative drug-holiday.
참고문헌 (31)
- Rogers MJ, "Cellular and molecular mechanisms of action of bisphosphonates", Cancer, 88, pp.2961~2978 (2000)
- Coleman RE, "Optimising treatment of bone metastases by arediaTM and zometaTM", Breast Cancer, 7, pp.361~369 (2000)
- Berenson JR, "American society of clinical oncology clinical practice guidelines : The role of bisphosphonates in multiple myeloma", J Clin Oncol, 20, pp.3719~3736 (2002)
- Bone HG, "Ten years' experience with alendronate for osteoporosis in postmenopausal women", N Engl J Med, 350, pp.1189~1199 (2004)
- Park HM, "The use of osteoporosis medications in Korea in 2008", J Bone Metab, 16, pp.87~93 (2009)
- Marx RE, "Pamidronate(aredia)and zoledronate(zometa)induced avascular necrosis of the jaws : A growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
- Khosla S, "Bisphosphonate-associated osteonecrosis of the jaw : Report of a task force of the american society for bone and mineral research", J Bone Miner Res, 22, pp.1479~1491 (2007)
- Rizzoli R, "Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis", Bone, 42, pp.841~847 (2008)
- 이정근, "Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report", 대한구강악안면외과학회지, 39(1), pp.9~13 (2013), 대한구강악안면외과학회
- Ruggiero SL, "American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update", J Oral Maxillofac Surg, 67, pp.2~12 (2009)
- Yarom N, "Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome", Osteoporosis Int, 18, pp.1363~1370 (2007)
- Thumbigere-Math V, "Bisphosphonate-related osteonecrosis of the jaw:Clinical features, risk factors, management, and treatment outcomes of 26 patients", J Oral Maxillofac Surg, 67, pp.1904~1913 (2009)
- 대한내분비학회, "비스포스포네이트와 관련한 악골(턱뼈) 괴사", Endocrinology and Metabolism, 24(4), pp.227~230 (2009), 대한내분비학회
- American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the Jaw-2014 update, "Ruggiero SL", ~ (2014)
- Lerman MA, "Conservative management of bisphosphonate-related osteonecrosis of the jaws : Staging and treatment outcomes", Oral Oncol, 49, pp.977~983 (2013)
- 이호경, "비스포스포네이트 관련 악골괴사(BRONJ)의 병기 2기에서의 외과적, 보존적 치료에 대한 비교 연구", Maxillofacial Plastic Reconstructive Surgery, 35(5), pp.302~309 (2013), 대한악안면성형재건외과학회
- Sedghizadeh PP, "Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy", J Oral Maxillofac Surg, 66, pp.767~775 (2008)
- Wanger G, "Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms", 115, pp.71~78 (2013)
- Scoletta M, "Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws : Preliminary results of a prospective study", Photomed Laser Surg, 28, pp.179~184 (2010)
- Damm DD, "Bisphosphonate-related osteonecrosis of the jaws : A potential alternative to drug-holidays", Gen Dent, 61, pp.33~38 (2013)
- Mavrokokki T, "Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in australia", J Oral Maxillofac Surg, 65, pp.415~423 (2007)
- Lo JC, "Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure", J Oral Maxillofac Surg, 68, pp.243~253 (2010)
- Vahtsevanos K, "Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw", J Clin Oncol, 27, pp.5356~5362 (2009)
- Saad F, "Incidence, risk factors, and outcomes of osteonecrosis of the jaw:Integrated analysis from three blinded activecontrolled phase III trials in cancer patients with bone metastases", Ann Oncol, 23, pp.1341~1347 (2012)
- Fehm T, "Bisphosphonate-induced osteonecrosis of the jaw(ONJ) : Incidence and risk factors in patients with breast cancer and gynecological malignancies", Gynecol Oncol, 112, pp.605~609 (2009)
- Kunchur R, "Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws", J Oral Maxillofac Surg, 67, pp.1167~1173 (2009)
- Kyrgidis A, "Bisphosphonate-related osteonecrosis of the jaws : A case-control study of risk factors in breast cancer patients", J Clin Oncol, 26, pp.4634~4638 (2008)
- Marx RE, "Oral bisphosphonateinduced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment.", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)
- Kwon YD, "Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67, pp.2644~2648 (2009)
- 송진우, "비스포스포네이트 관련 악골괴사환자의 혈청 C-terminal cross linking telopeptide 수치에 따른 위험도 평가와 질환의 심도 및 조기 수술 후 치유 사이의 상관관계", 대한구강악안면외과학회지, 37(1), pp.1~8 (2011), 대한구강악안면외과학회
- Saad F, "Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer", Urol Oncol, 30, pp.369~378 (2012)